Literature DB >> 17041451

Hypertension and elevated ESR as diagnostic features of Takayasu arteritis in children.

Evan Fieldston1, Daniel Albert, Terri Finkel.   

Abstract

Takayasu arteritis (TA) is an inflammatory disease of the aorta and its branches. Delay in diagnosis is a common problem for adults and children. Although early manifestations are nonspecific (i.e., malaise, fever, anorexia, weight loss, myalgia, arthralgia/arthritis, elevated acute phase reactants), the clinical features that lead to diagnosis often appear suddenly and are related to vascular involvement. Hypertension, which is rare in children, and elevated ESR are found in most patients with TA. The authors hypothesized that these features, then, could be used as way to raise the clinical suspicion of TA. A total of 190 young patients with TA were retrospectively analyzed from local records and the literature to find the signs and symptoms associated with the disease that could be used to educate caregivers about when to suspect TA and to provide a screening tool for the disease. Hypertension and elevated ESR are found in most patients with TA. For this local study group, the sensitivity of this combination was 67%. Including the literature sources for which patient-specific information was available, the overall sensitivity was 65%. Thus, the combination of hypertension and elevated ESR in pediatric patients should merit further screening for TA, particularly in those with systemic complaints. Physical examination should focus on pulse abnormalities. Further evaluation should involve extensive imaging of the vascular system.

Entities:  

Year:  2003        PMID: 17041451     DOI: 10.1097/01.RHU.0000073436.33243.2c

Source DB:  PubMed          Journal:  J Clin Rheumatol        ISSN: 1076-1608            Impact factor:   3.517


  8 in total

1.  Management of the renovascular disease in children with Takayasu arteritis.

Authors:  Kjell Tullus
Journal:  Pediatr Nephrol       Date:  2015-05-16       Impact factor: 3.714

2.  Evaluation of routinely performed hematological and biochemical parameters for the prognosis of acute ischemic stroke patients.

Authors:  Amit R Nayak; Rajpal S Kashyap; Dinesh Kabra; Prashant Deoras; Hemant J Purohit; Girdhar M Taori; Hatim F Daginawala
Journal:  Neurol Sci       Date:  2011-08-24       Impact factor: 3.307

3.  The presentation and management of hypertension in a large cohort of Takayasu arteritis.

Authors:  Yu Qi; Lirui Yang; Huimin Zhang; Erpeng Liang; Lei Song; Jun Cai; Xiongjing Jiang; Yubao Zou; Haiyan Qian; Haiying Wu; Xianliang Zhou; Rutai Hui; Deyu Zheng
Journal:  Clin Rheumatol       Date:  2017-12-14       Impact factor: 2.980

4.  Clinical characteristics, interdisciplinary treatment and follow-up of 14 children with Takayasu arteritis.

Authors:  Wei-Hua Zhu; Lai-Gen Shen; Henning Neubauer
Journal:  World J Pediatr       Date:  2010-11-16       Impact factor: 2.764

5.  Clinical characteristics, imaging phenotypes and events free survival in Takayasu arteritis patients with hypertension.

Authors:  Sun Ying; Wu Sifan; Wang Yujiao; Chen Rongyi; Huang Qingrong; Ma Lili; Chen Huiyong; Jiang Lindi
Journal:  Arthritis Res Ther       Date:  2021-07-21       Impact factor: 5.156

6.  Takayasu Arteritis in the pediatric population: a contemporary United States-based single center cohort.

Authors:  Heidi S Szugye; Andrew S Zeft; Steven J Spalding
Journal:  Pediatr Rheumatol Online J       Date:  2014-06-04       Impact factor: 3.054

7.  Revascularization of Concurrent Renal and Cerebral Artery Stenosis in a 14-Year-Old Girl with Takayasu Arteritis and Moyamoya Syndrome.

Authors:  Meng Luen Lee; Ming Yuh Chang; Tung Ming Chang; Rei Cheng Yang; Ming Che Chang; Albert D Yang
Journal:  J Korean Med Sci       Date:  2018-03-05       Impact factor: 2.153

8.  Takayasu arteritis with an initial presentation of chronic monoarthritis mimicking oligoarticular juvenile idiopathic arthritis.

Authors:  Maynart Sukharomana; Sorawit Viravan; Nuntawan Piyaphanee; Sirirat Charuvanij
Journal:  Pediatr Rep       Date:  2018-07-09
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.